ロード中...
Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
Vulvovaginal atrophy (VVA) and dryness are common symptoms of the decline in endogenous production of estrogen at menopause and often result in dyspareunia. Yet while 10% to 40% of women experience discomfort due to VVA, it is estimated that only 25% seek medical help. The main goals of treatment fo...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2971714/ https://ncbi.nlm.nih.gov/pubmed/21072280 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|